1. Захаров В.В., Яхно Н.Н. Нарушения памяти. М.: ГЭОТАР-МЕД, 2003. / Zakharov V.V., Iakhno N.N. Narusheniia pamiati. M.: GEOTAR-MED, 2003. [in Russian]
2. Яхно Н.Н., Захаров В.В. Нарушения памяти в неврологической практике. Неврол. журн. 1997; 3 (4): 4–9. / Iakhno N.N., Zakharov V.V. Narusheniia pamiati v nevrologicheskoi praktike. Nevrol. zhurn. 1997; 3 (4): 4–9. [in Russian]
3. Lovenstone S, Gauthier S. Management of dementia. London: Martin Dunitz, 2001.
4. Wilcock GK, Bucks RS, Rockwood К. Diagnosis and management of dementia. A manual for memory disorders team. Oxford, NY: Oxford University Press, 1999; p. 251.
5. Яхно Н.Н., Захаров В.В., Локшина А.Б. и др. Деменции: руководство для врачей. 3-е изд. М.: МЕДпреcс-информ, 2011. / Iakhno N.N., Zakharov V.V., Lokshina A.B. i dr. Dementsii: rukovodstvo dlia vrachei. 3-e izd. M.: MEDprecs-inform, 2011. [in Russian]
6. Clozel M, Kuhn H, Hefti F, Baumgartner HR. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition. Hypertension 1991; 18 (2): 132–41.
7. Murray AM. Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis 2008; 15 (2): 123–32.
8. Khatri M, Nickolas T, Moon YP et al. CKD associates with cognitive decline. J Am Soc Nephrol 2009; 20 (11): 2427–32.
9. Fazekas G, Fazekas F, Schmidt R et al. Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment. J Neurol Sci 1995; 134 (1–2): 83–8.
10. Kurella M, Chertow GM, Fried LF et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol 2005; 16 (7): 2127–33.
11. Seliger SL, Siscovick DS, Stehman-Breen CO et al. Moderate renal impairment and risk of dementia among older adults: The Cardiovascular Health Cognition study. J Am Soc Nephrol 2004; 15 (7): 1904–11.
12. Slinin Y, Paudel ML, Ishani A et al. Kidney function and cognitive performance and decline in older men. J Am Geriatr Soc 2008; 56 (11): 2082–8.
13. Elias MF, Elias PK, Seliger SL et al. Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant 2009; 24 (8): 2446–52.
14. Kodl CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus. Endocr Rev 2008; 29 (4): 494–511.
15. Gonder-Frederick LA, Zrebiec JF, Bauchowitz AU et al. Cognitive function isdisrupted by both hypo- and hyperglycemia in schoolaged children with type 1 diabetes: a field study. Diabetes Сare 2009; 32 (6): 1101–6.
16. Xiao-jun Cai, Hui-qin Xu, Yi Lu. C-peptide and Diabetic Encephalopathy. Chin Med Sci J 2011; 26 (2): 119–25.
17. Чуйко М.Р., Бодыхов М.К., Скворцова В.И. Характеристика и особенности течения энцефалопатии при инсулинзависимом сахарном диабете. Журн. неврологии и психиатрии им. С.С.Корсакова. 2010; 5: 4–8. / Chuiko M.R., Bodykhov M.K., Skvortsova V.I. Kharakteristika i osobennosti techeniia entsefalopatii pri insulinzavisimom sakharnom diabete. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2010; 5: 4–8. [in Russian]
18. Patino-Fernandez AM, Delamater AM, Applegate EB et al. Neurocognitive functioning in preschool-age children with type 1 diabetes mellitus. Pediatric Diabetes 2010; 11 (6): 424–30.
19. Brands AMA, Biessels GJ, De Haan EHF et al. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 2005; 28: 726–35.
20. Perantie DC, Koller JM, Weaver PM et al. Prospectively determined impact of type 1 diabetes on brain volume during development. Diabetes 2011; 60 (11): 3006–14.
21. Brands AM, Biessels GJ, Kappelle LJ et al. Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: a comparative study. Dement Geriatr Cogn Disord 2007; 23 (5): 343–50.
22. Ho MS, Weller NJ, Ives FJ et al. Prevalence of structural central nervous system abnormalities in early-onset type 1 diabetes mellitus. J Pediatr 2008; 153: 385–90.
23. Mijnhout GS, Scheltens P, Diamant M et al. Diabetic encephalopathy: A concept in need of a definition. Diabetologia 2006; 49: 1447–8.
24. Strachan MW, Reynolds RM, Frier BM et al. The relationship between type 2 diabetes and dementia. Br Med Bui 2008; 88: 131–46.
25. Fontbonne A, Berr С, Ducimetiere P, Alperovitch A. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 2001; 24 (2): 366–70.
26. Messier C. Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging. Neurobiol Aging 2005; 26 (1): 26–30.
27. Biessels GJ, Staekenborg S, Brunner E et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006; 5 (1): 64–74.
28. Ott A, Stolk RP, Hofman A et al. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 1996; 39 (11): 1392–7.
29. Yoshitake Т, Kiyohara Y, Kato I et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995; 45 (6): 1161–8.
30. Строков И.А., Моргоева Ф.Э., Строков К.И. и др. Терапевтическая коррекция диабетической полиневропатии и энцефалопатии Актовегином. Рус. мед. журн. 2006; 9: 698–703. / Strokov I.A., Morgoeva F.E., Strokov K.I. i dr. Terapevticheskaia korrektsiia diabeticheskoi polinevropatii i entsefalopatii Aktoveginom. Rus. med. zhurn. 2006; 9: 698–703. [in Russian]
31. Чугунов П.А., Семенова И.В. Сахарный диабет и когнитивные нарушения. Сахарный диабет. 2008; 1 (38): 61–8. / Chugunov P.A., Semenova I.V. Sakharnyi diabet i kognitivnye narusheniia. Sakharnyi diabet. 2008; 1 (38): 61–8. [in Russian]
32. Reaven G, Thompson L, Nahum D, Haskins E. Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 1990; 13: 16–21.
33. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002; 287: 2570–81.
34. Ефимов А.С. Диабетические ангиопатии. М.: Медицина, 1989. / Efimov A.S. Diabeticheskie angiopatii. M.: Meditsina, 1989. [in Russian]
35. Wredling R, Levander S, Adamson U. Permanent neuropsychological impairment after recurrent episodes of severe hypoglicaemia in men. Diabetologia 1990; 33: 152–7.
36. Полунина Т.Е., Маев И.В. Печеночная энцефалопатия: алгоритм дифференциальной диагностики и тактика ведения. Рус. мед. журн. 2010; 18 (5): 291–7. / Polunina T.E., Maev I.V. Pechenochnaia entsefalopatiia: algoritm differentsial'noi diagnostiki i taktika vedeniia. Rus. med. zhurn. 2010; 18 (5): 291–7. [in Russian]
37. Garcia A, Zanibbi K. Homocysteine and cognitive function in elderly people. CMAJ 2004; 171 (8): 897–904.
38. Дамулин И.В. Патогенетические, диагностические и терапевтические аспекты сосудистых когнитивных нарушений. Consilium Medicum. 2006; 8 (8): 80–5. / Damulin I.V. Patogeneticheskie, diagnosticheskie i terapevticheskie aspekty sosudistykh kognitivnykh narushenii. Consilium Medicum. 2006; 8 (8): 80–5. [in Russian]
39. Stein G, Muller A, Busch M et al. Homocysteine, its metabolites, and B-group vitamins in renal transplant patients. Kidney Int Suppl 2001; 78: S262–5.
40. Рогова И.В., Фомин В.В., Дамулин И.В. и др. Сосудистые когнитивные нарушения при хронической болезни почек. Неврология, нейропсихиатрия, психосоматика. 2015; 1: 11–8. / Rogova I.V., Fomin V.V., Damulin I.V. i dr. Sosudistye kognitivnye narusheniia pri khronicheskoi bolezni pochek. Nevrologiia, neiropsikhiatriia, psikhosomatika. 2015; 1: 11–8. [in Russian]
41. Prins ND, Den Heijer T, Hofman A et al. Rotterdam Scan Study. Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology 2002; 59 (9): 1375–80.
42. Sachdev P. Homocysteine, cerebrovascular disease and brain atrophy. J Neurol Sci 2004; 226 (1–2): 25–9.
43. Гусев Е.И., Скворцова В.И. Ишемия головного мозга. М.: Медицина, 2001. / Gusev E.I., Skvortsova V.I. Ishemiia golovnogo mozga. M.: Meditsina, 2001. [in Russian]
44. Дамулин И.В., Шмидт Т.Е. Неврологические расстройства при алкоголизме. Невролог. журн. 2004; 9 (2): 4–10. / Damulin I.V., Shmidt T.E. Nevrologicheskie rasstroistva pri alkogolizme. Nevrolog. zhurn. 2004; 9 (2): 4–10. [in Russian]
45. Harper C, Corbett D. Alcoholism and dementia. In: The Neuropathology of Dementia. Ed. by M.M.Esiri, J.H.Morris. Cambridge: Cambridge University Press, 1997; p. 294–306.
46. Renner JA, Morris JC. Alcohol-associated dementia. /In: Handbook of Dementing Illnesses. Ed. by J.C.Morris. New York etc.: Marcel Dekker, Inc., 1994; p. 393–412.
47. Зиматкин С.М., Пронько С.П., Бубен А.Л., Лиопо А.В. Материалы международного симпозиума «Современные аспекты изучения алкогольной и наркотической зависимости». Гродно, 2004; с. 48–53. / Zimatkin S.M., Pron'ko S.P., Buben A.L., Liopo A.V. Materialy mezhdunarodnogo simpoziuma «Sovremennye aspekty izucheniia alkogol'noi i narkoticheskoi zavisimosti». Grodno, 2004; s. 48–53. [in Russian]
48. Fadda F, Rossetti ZL. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog Neurobiol 1998; 56 (4): 385–431.
49. Harper CG, Kril JJ, Daly J. Alcohol-Induced Brain Damage. W.A.Hunt, S.J.Nixon (eds.). NIIAAA Res Monograph 1993; 22: 39–70.
50. Ratti MT, Bo P, Giardini A, Soragna D. Chronic alcoholism and the frontal lobe: which executive functions are impaired? Acta Neurol Scand 2002; 105: 276–81.
51. Harper CG. The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain? J Neuropathol Exp Neurol 1998; 57 (2): 101–10.
52. Arango V, Underwood MD, Pauler DK et al. Differential age-related loss of pigmented locus coeruleus neurons in suicides, alcoholics, and alcoholic suicides. Alcohol Clin Exp Res 1996; 20 (7): 1141–7.
53. Franke H, Kittner H, Berger P et al. The reaction of astrocytes and neurons in the hippocampus of adult rats during chronic ethanol treatment and correlations to behavioral impairments. Alcohol 1997; 14 (5): 445–54.
54. Donaghy M. Toxic and environmental disorders of the nervous system. In: Brain’s Diseases of the Nervous System. Tenth edition. Ed. by J.Walton. Oxford etc.: Oxford University Press, 1993; p. 513–29.
55. Greenberg DA, Aminoff MJ, Simon RP. Clinical Neurology. Fifth edition. N.Y. etc.: Lange Medical Books/McGraw-Hill, 2002; p. 1–70.
56. Schlapfer TE. Alcohol and the brain – morphological and functional brain changes. Ther Umsch 2000; 57 (4): 191–5.
57. Chandler LJ, Sumners C, Crews FT. Ethanol inhibits NMDA receptor-mediated excitotoxicity in rat primary neuronal cultures. Alcohol Clin Exp Res 1993; 17 (1): 54–60.
58. Montoliu C, Valles S, Renau-Piqueras J, Guerri C. Ethanol-induced oxygen radical formation and lipid peroxidation in rat brain: effect of chronic alcohol consumption. J Neurochem 1994; 63 (5): 1855–62.
59. Nordman R, Ribiere C, Rouach H. Implication of free radical mechanisms in ethanol-induced cellular injury. Free Radic Biol Med 1992; 12 (3): 219–40.
60. Thomson AD. Mechanisms of vitamin deficiency in chronic alcohol misusers and the development of the Wernicke-Korsakoff syndrome. Alcohol Alcohol Suppl 2000; 35 (1): 2–7.
61. Estruch R, Bono G, Laine P et al. Brain imaging in alcoholism. Eur J Neurol 1998; 5: 119–35.
62. Finkelstein JD, Mudd SH, Irreverre F, Laster L. Homocystinuria due to cystathionine synthetase deficiency: the mode of inheritance. Science 1964; 146: 785–7.
63. Баранова И.Е., Большакова О.О. Клиническое значение гомоцистеинемии. Артериальная гипертензия. 2004; 10 (1): 45–50. / Baranova I.E., Bol'shakova O.O. Klinicheskoe znachenie gomotsisteinemii. Arterial'naia gipertenziia. 2004; 10 (1): 45–50. [in Russian]
64. Люсов В.А., Лебедева А.Ю., Соболева В.Н. и др. Гипергомоцистеинемия, частота рецидивирующих расстройств коронарного кровообращения и эффективность эндоваскулярного лечения у больных инфарктом миокарда. Клиницист. 2007; 5: 16–22. / Liusov V.A., Lebedeva A.Iu., Soboleva V.N. i dr. Gipergomotsisteinemiia, chastota retsidiviruiushchikh rasstroistv koronarnogo krovoobrashcheniia i effektivnost' endovaskuliarnogo lecheniia u bol'nykh infarktom miokarda. Klinitsist. 2007; 5: 16–22. [in Russian]
65. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of atherosclerosis. Am J Pathol 1969; 56: 111–28.
66. Lonn E, Held C, Arnold JM et al. Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial. Can J Cardiol 2006; 22 (1): 47–53.
67. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999; 354: 407–13.
68. McIlroy SP, Dynan KB, Lawson JT et al. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002; 33 (10): 2351–6.
69. Welch G, Loscalo J. Homocysteine and atherosclerosis. N Engl J Med 1998; 338: 15: 1042–50.
70. Sen S, Reddy PL, Grewal RP et al. Hyperhomocysteinemia is associated with aortic atheroma progression in stroke/TIA patients. Front Neurol 2010; 1: 131.
71. Leblhuber F, Walli J, Artner-Dworzak E et al. Hyperhomocysteinemia in dementia. J Neural Transm 2000; 107 (12): 1469–74.
72. Seshadri S, Beiser A, Selhub J et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 2002; 346 (7): 476–83.
73. Schafer JH, Glass TA, Bolla KI et al. Homocysteine and cognitive function in a population-based study of older adults. J Am Geriatr Soc 2005; 53 (3): 381–8.
74. Зорилова И.В., Суслина З.А., Иллариошкин С.Н., Кистенев Б.А. Наследственно обусловленная гипергомоцистеинемия в патогенезе ишемического инсульта у лиц молодого возраста. Неврол. журн. 2005; 10 (2): 14–7. / Zorilova I.V., Suslina Z.A., Illarioshkin S.N., Kistenev B.A. Nasledstvenno obuslovlennaia gipergomotsisteinemiia v patogeneze ishemicheskogo insul'ta u lits molodogo vozrasta. Nevrol. zhurn. 2005; 10 (2): 14–7. [in Russian]
75. Loscalzo J. Homocysteine and dementias. N Engl J Med 2002; 346 (7): 466–8.
76. McMahon JA, Green TJ, Skeaff CM et al. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 2006; 354 (26): 2764–72.
77. Walker JG, Batterham PJ, Mackinnon AJ et al. Oral folic acid and vitamin B12 supplementation to prevent cognitive decline in community dwelling older adults with depressive symptoms – the Beyond Ageing Project: a randomized controlled trial. Am J Clin Nutr 2012; 95 (1): 194–203.
78. Камчатнов П.Р., Дамулин И.В. Когнитивные нарушения при дефиците витамина В12, фолиевой кислоты и гипергомоцистеинемии. Клиницист 2015; 1: 18–23. / Kamchatnov P.R., Damulin I.V. Kognitivnye narusheniia pri defitsite vitamina V12, folievoi kisloty i gipergomotsisteinemii. Klinitsist 2015; 1: 18–23. [in Russian]
79. Clark C.M. Metabolic and nutritional disorders associated with dementia. In: J.C.Morris, J.E.Galvin, D.M.Holzman (eds.). Handbook of Dementing Illnesses. N.Y.: Marcel Dekker, Inc., 1994; p. 413–39.
80. Wahlund LO, Basun H, Waldemar G. Reversible or arrestable dementias. In: N.Qizilbash et al. (eds.). Evidence-based Dementia Practice. Oxford: Blackwell Sciences, 2002; р. 330–40.
81. Abyad A. Prevalence of vitamin B12 deficiency among demented patients and cognitive recovery with cobalamin replacement. J Nutr Health Aging 2002; 6 (4): 254–60.
82. Rietsema WJ. Unexpected recovery of moderate cognitive impairment on treatment with oral methylcobalamin. J Am Geriatr Soc 2014; 62 (8): 1611–2.
83. Clayton PT, Smith I, Harding В et al. Subacute combined degeneration of the cord, dementia, and parkinsonism due to an inborn error of folate metabolism. J Neurol Neurosurg Psychiatry 1986; 49: 920–7.
84. Heap BJ, Mumford JD. Chronic giardiasis with vitamin B12 and folate deficiency presenting with psychiatric symptoms. J Roy Amy Med Corps 1989; 135: 25–6.
85. Moore E, Mander A, Ames D et al. Cognitive impairment and vitamin B12: a review. Int Psychogeriatr 2012; 24 (4): 541–56.
86. Reynolds EH. Folic acid, ageing, depression, and dementia. BMJ 2002; 324 (7352): 1512–5.
87. Lancowsky P. Congenital malabsorption of folate. J Am Med 1970; 48: 580–3.
88. Luhby AL, Cooperman JM. Congenital megaloblastic anemia and progressive central nervous system degeneration. Further clinical and physiological characterization and therapy of syndrome due to inborn error of folate transport. American Pediatric Society, Inc., Annual Meeting, Atlantic City, 1967.
89. Lever EG, Elwes RD, Williams A et al. Subacutecombinated degeneration of the cord due to folate deficiency: response to methyl folate treatment. J Neurol Neurosurg Psychiatry 1986; 49: 1203–7.
90. Luhby AL, Eagle FJ, Roth Ε et al. Relapsing megaloblastic anemia in an infant due to a specific defect in gastrointestinal absorption of folic acid. J Am Dis Child 1961; 102: 482–3.
91. Дамулин И.В. Деменции при дефицитарных состояниях и алкоголизме. Неврол. журн. 2005; 5: 4–8. / Damulin I.V. Dementsii pri defitsitarnykh sostoianiiakh i alkogolizme. Nevrol. zhurn. 2005; 5: 4–8. [in Russian]
92. Guidolin L, Vignoli A, Canger R. Worsening in seizure frequency and severity in relation to folic acid administration. Eur J Neurol 1998; 5 (3): 301–3.
93. Agnew-Blais JС, Wassertheil-Smoller S, Kang JH et al. Folate, vitamin B-6, and vitamin B-12 intake and mild cognitive impairment and probable dementia in the Women's Health Initiative Memory Study. J Acad Nutr Diet 2015; 115 (2): 231–41.
94. Разводовский Ю.Е. Алкогольное поражение мозга. Мед. новости. 2006; 1: 13–7. / Razvodovskii Iu.E. Alkogol'noe porazhenie mozga. Med. novosti. 2006; 1: 13–7. [in Russian]
95. Гаврилова С.И. Фармакотерапия болезни Альцгеймера. 2-е изд., перераб. и доп. М., 2007; с. 360. / Gavrilova S.I. Farmakoterapiia bolezni Al'tsgeimera. 2-e izd., pererab. i dop. M., 2007; s. 360. [in Russian]
96. Дамулин И.В. Болезнь Альцгеймера и сосудистая деменция. Под ред. Н.Н.Яхно. М., 2002; с. 85. / Damulin I.V. Bolezn' Al'tsgeimera i sosudistaia dementsiia. Pod red. N.N.Iakhno. M., 2002; s. 85. [in Russian]
97. Левин О.С. Диагностика и лечение деменции в клинической практике. М., 2010; с. 256. / Levin O.S. Diagnostika i lechenie dementsii v klinicheskoi praktike. M., 2010; s. 256. [in Russian]
98. Andrieux S, Amouyal K, Renish W et al. The consumption of vasodilators and Ginkgo biloba (Egb 761) in a population of 7598 women over the age of 75 years. Res Pract Alzheimer’s Dis 2001; 5: 57–68.
99. Преображенская И.С. Ноотропные препараты в гериатрической практике. РМЖ 2004; 5 (12): 256–61. / Preobrazhenskaia I.S. Nootropnye preparaty v geriatricheskoi praktike. RMZh 2004; 5 (12): 256–61. [in Russian]
100. Knopman DS. Current treatment of mild cognitive impairment and Alzheimer’s disease. Curr Neurol Nerosci Rep 2006; 6 (5): 365–71.
101. Grima NA, Pase MP, Macpherson H, Pipingas A. The effects of multivitamins on cognitive performance: A systematic review and meta-analysis. J Alzheimer’s Dis. 2012; 29: 561–9.
102. Kennedy DO, Haskell CF. Vitamins and cognition: What is the evidence? Drugs 2011; 71: 1957–71.
103. Heseker H, Kubler W, Pudel V, Westenhofer J. Interaction of vitamins with mental performance. Bibl Nutr Dieta 1995; 52: 43–55.
104. Kennedy DO, Veasey R, Watson A et al. Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males. Psychopharmacology 2010; 211: 55–68.
105. Kennedy DO, Veasey RC, Watson AW et al. Vitamins and psychological functioning: A mobile phone assessment of the effects of a B vitamin complex, vitamin C and minerals on cognitive performance and subjective mood and energy. Hum Psychopharmacol Clin Exp 2011; 26: 538–47.
106. Harris E, Kirk J, Rowsell R et al. The effect of multivitamin supplementation on mood and stress in healthy older men. Hum Psychopharmacol Clin Exp 2011; 26: 560–7.
107. Stough C, Scholey A, Lloyd J et al. The effect of 90 day administration of a high dose vitamin B – Complex on work stress. Hum Psychopharmacol Clin Exp 2011; 26: 470–6.
108. Haskell CF, Robertson B, Jones E et al. Effects of a multi-Vitamin/mineral supplement on cognitive function and fatigue during extended multi-Tasking. Hum Psychopharmacol Clin 2010; 25: 448–61.
109. www.berocca.ru.
110. McGarel C, Pentieva K, Strain JJ, McNulty H. Emerging roles for folate and related B-vitamins in brain health across the lifecycle. Proc Nutr Soc 2015; 74 (1): 46–55.
111. Scholey A, Bauer I, Neale C et al. Acute effects of different multivitamin mineral preparations with and without Guaraná on mood, cognitive performance and functional brain activation. Nutrients 2013; 5 (9): 3589–604.

________________________________________________

1. Zakharov V.V., Iakhno N.N. Narusheniia pamiati. M.: GEOTAR-MED, 2003. [in Russian]
2. Iakhno N.N., Zakharov V.V. Narusheniia pamiati v nevrologicheskoi praktike. Nevrol. zhurn. 1997; 3 (4): 4–9. [in Russian]
3. Lovenstone S, Gauthier S. Management of dementia. London: Martin Dunitz, 2001.
4. Wilcock GK, Bucks RS, Rockwood К. Diagnosis and management of dementia. A manual for memory disorders team. Oxford, NY: Oxford University Press, 1999; p. 251.
5. Iakhno N.N., Zakharov V.V., Lokshina A.B. i dr. Dementsii: rukovodstvo dlia vrachei. 3-e izd. M.: MEDprecs-inform, 2011. [in Russian]
6. Clozel M, Kuhn H, Hefti F, Baumgartner HR. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition. Hypertension 1991; 18 (2): 132–41.
7. Murray AM. Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis 2008; 15 (2): 123–32.
8. Khatri M, Nickolas T, Moon YP et al. CKD associates with cognitive decline. J Am Soc Nephrol 2009; 20 (11): 2427–32.
9. Fazekas G, Fazekas F, Schmidt R et al. Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment. J Neurol Sci 1995; 134 (1–2): 83–8.
10. Kurella M, Chertow GM, Fried LF et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol 2005; 16 (7): 2127–33.
11. Seliger SL, Siscovick DS, Stehman-Breen CO et al. Moderate renal impairment and risk of dementia among older adults: The Cardiovascular Health Cognition study. J Am Soc Nephrol 2004; 15 (7): 1904–11.
12. Slinin Y, Paudel ML, Ishani A et al. Kidney function and cognitive performance and decline in older men. J Am Geriatr Soc 2008; 56 (11): 2082–8.
13. Elias MF, Elias PK, Seliger SL et al. Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant 2009; 24 (8): 2446–52.
14. Kodl CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus. Endocr Rev 2008; 29 (4): 494–511.
15. Gonder-Frederick LA, Zrebiec JF, Bauchowitz AU et al. Cognitive function isdisrupted by both hypo- and hyperglycemia in schoolaged children with type 1 diabetes: a field study. Diabetes Сare 2009; 32 (6): 1101–6.
16. Xiao-jun Cai, Hui-qin Xu, Yi Lu. C-peptide and Diabetic Encephalopathy. Chin Med Sci J 2011; 26 (2): 119–25.
17. Chuiko M.R., Bodykhov M.K., Skvortsova V.I. Kharakteristika i osobennosti techeniia entsefalopatii pri insulinzavisimom sakharnom diabete. Zhurn. nevrologii i psikhiatrii im. S.S.Korsakova. 2010; 5: 4–8. [in Russian]
18. Patino-Fernandez AM, Delamater AM, Applegate EB et al. Neurocognitive functioning in preschool-age children with type 1 diabetes mellitus. Pediatric Diabetes 2010; 11 (6): 424–30.
19. Brands AMA, Biessels GJ, De Haan EHF et al. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 2005; 28: 726–35.
20. Perantie DC, Koller JM, Weaver PM et al. Prospectively determined impact of type 1 diabetes on brain volume during development. Diabetes 2011; 60 (11): 3006–14.
21. Brands AM, Biessels GJ, Kappelle LJ et al. Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: a comparative study. Dement Geriatr Cogn Disord 2007; 23 (5): 343–50.
22. Ho MS, Weller NJ, Ives FJ et al. Prevalence of structural central nervous system abnormalities in early-onset type 1 diabetes mellitus. J Pediatr 2008; 153: 385–90.
23. Mijnhout GS, Scheltens P, Diamant M et al. Diabetic encephalopathy: A concept in need of a definition. Diabetologia 2006; 49: 1447–8.
24. Strachan MW, Reynolds RM, Frier BM et al. The relationship between type 2 diabetes and dementia. Br Med Bui 2008; 88: 131–46.
25. Fontbonne A, Berr С, Ducimetiere P, Alperovitch A. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 2001; 24 (2): 366–70.
26. Messier C. Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging. Neurobiol Aging 2005; 26 (1): 26–30.
27. Biessels GJ, Staekenborg S, Brunner E et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006; 5 (1): 64–74.
28. Ott A, Stolk RP, Hofman A et al. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 1996; 39 (11): 1392–7.
29. Yoshitake Т, Kiyohara Y, Kato I et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995; 45 (6): 1161–8.
30. Strokov I.A., Morgoeva F.E., Strokov K.I. i dr. Terapevticheskaia korrektsiia diabeticheskoi polinevropatii i entsefalopatii Aktoveginom. Rus. med. zhurn. 2006; 9: 698–703. [in Russian]
31. Chugunov P.A., Semenova I.V. Sakharnyi diabet i kognitivnye narusheniia. Sakharnyi diabet. 2008; 1 (38): 61–8. [in Russian]
32. Reaven G, Thompson L, Nahum D, Haskins E. Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 1990; 13: 16–21.
33. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002; 287: 2570–81.
34. Efimov A.S. Diabeticheskie angiopatii. M.: Meditsina, 1989. [in Russian]
35. Wredling R, Levander S, Adamson U. Permanent neuropsychological impairment after recurrent episodes of severe hypoglicaemia in men. Diabetologia 1990; 33: 152–7.
36. Polunina T.E., Maev I.V. Pechenochnaia entsefalopatiia: algoritm differentsial'noi diagnostiki i taktika vedeniia. Rus. med. zhurn. 2010; 18 (5): 291–7. [in Russian]
37. Garcia A, Zanibbi K. Homocysteine and cognitive function in elderly people. CMAJ 2004; 171 (8): 897–904.
38. Damulin I.V. Patogeneticheskie, diagnosticheskie i terapevticheskie aspekty sosudistykh kognitivnykh narushenii. Consilium Medicum. 2006; 8 (8): 80–5. [in Russian]
39. Stein G, Muller A, Busch M et al. Homocysteine, its metabolites, and B-group vitamins in renal transplant patients. Kidney Int Suppl 2001; 78: S262–5.
40. Rogova I.V., Fomin V.V., Damulin I.V. i dr. Sosudistye kognitivnye narusheniia pri khronicheskoi bolezni pochek. Nevrologiia, neiropsikhiatriia, psikhosomatika. 2015; 1: 11–8. [in Russian]
41. Prins ND, Den Heijer T, Hofman A et al. Rotterdam Scan Study. Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology 2002; 59 (9): 1375–80.
42. Sachdev P. Homocysteine, cerebrovascular disease and brain atrophy. J Neurol Sci 2004; 226 (1–2): 25–9.
43. Gusev E.I., Skvortsova V.I. Ishemiia golovnogo mozga. M.: Meditsina, 2001. [in Russian]
44. Damulin I.V., Shmidt T.E. Nevrologicheskie rasstroistva pri alkogolizme. Nevrolog. zhurn. 2004; 9 (2): 4–10. [in Russian]
45. Harper C, Corbett D. Alcoholism and dementia. In: The Neuropathology of Dementia. Ed. by M.M.Esiri, J.H.Morris. Cambridge: Cambridge University Press, 1997; p. 294–306.
46. Renner JA, Morris JC. Alcohol-associated dementia. /In: Handbook of Dementing Illnesses. Ed. by J.C.Morris. New York etc.: Marcel Dekker, Inc., 1994; p. 393–412.
47. Zimatkin S.M., Pron'ko S.P., Buben A.L., Liopo A.V. Materialy mezhdunarodnogo simpoziuma «Sovremennye aspekty izucheniia alkogol'noi i narkoticheskoi zavisimosti». Grodno, 2004; s. 48–53. [in Russian]
48. Fadda F, Rossetti ZL. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog Neurobiol 1998; 56 (4): 385–431.
49. Harper CG, Kril JJ, Daly J. Alcohol-Induced Brain Damage. W.A.Hunt, S.J.Nixon (eds.). NIIAAA Res Monograph 1993; 22: 39–70.
50. Ratti MT, Bo P, Giardini A, Soragna D. Chronic alcoholism and the frontal lobe: which executive functions are impaired? Acta Neurol Scand 2002; 105: 276–81.
51. Harper CG. The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain? J Neuropathol Exp Neurol 1998; 57 (2): 101–10.
52. Arango V, Underwood MD, Pauler DK et al. Differential age-related loss of pigmented locus coeruleus neurons in suicides, alcoholics, and alcoholic suicides. Alcohol Clin Exp Res 1996; 20 (7): 1141–7.
53. Franke H, Kittner H, Berger P et al. The reaction of astrocytes and neurons in the hippocampus of adult rats during chronic ethanol treatment and correlations to behavioral impairments. Alcohol 1997; 14 (5): 445–54.
54. Donaghy M. Toxic and environmental disorders of the nervous system. In: Brain’s Diseases of the Nervous System. Tenth edition. Ed. by J.Walton. Oxford etc.: Oxford University Press, 1993; p. 513–29.
55. Greenberg DA, Aminoff MJ, Simon RP. Clinical Neurology. Fifth edition. N.Y. etc.: Lange Medical Books/McGraw-Hill, 2002; p. 1–70.
56. Schlapfer TE. Alcohol and the brain – morphological and functional brain changes. Ther Umsch 2000; 57 (4): 191–5.
57. Chandler LJ, Sumners C, Crews FT. Ethanol inhibits NMDA receptor-mediated excitotoxicity in rat primary neuronal cultures. Alcohol Clin Exp Res 1993; 17 (1): 54–60.
58. Montoliu C, Valles S, Renau-Piqueras J, Guerri C. Ethanol-induced oxygen radical formation and lipid peroxidation in rat brain: effect of chronic alcohol consumption. J Neurochem 1994; 63 (5): 1855–62.
59. Nordman R, Ribiere C, Rouach H. Implication of free radical mechanisms in ethanol-induced cellular injury. Free Radic Biol Med 1992; 12 (3): 219–40.
60. Thomson AD. Mechanisms of vitamin deficiency in chronic alcohol misusers and the development of the Wernicke-Korsakoff syndrome. Alcohol Alcohol Suppl 2000; 35 (1): 2–7.
61. Estruch R, Bono G, Laine P et al. Brain imaging in alcoholism. Eur J Neurol 1998; 5: 119–35.
62. Finkelstein JD, Mudd SH, Irreverre F, Laster L. Homocystinuria due to cystathionine synthetase deficiency: the mode of inheritance. Science 1964; 146: 785–7.
63. Baranova I.E., Bol'shakova O.O. Klinicheskoe znachenie gomotsisteinemii. Arterial'naia gipertenziia. 2004; 10 (1): 45–50. [in Russian]
64. Liusov V.A., Lebedeva A.Iu., Soboleva V.N. i dr. Gipergomotsisteinemiia, chastota retsidiviruiushchikh rasstroistv koronarnogo krovoobrashcheniia i effektivnost' endovaskuliarnogo lecheniia u bol'nykh infarktom miokarda. Klinitsist. 2007; 5: 16–22. [in Russian]
65. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of atherosclerosis. Am J Pathol 1969; 56: 111–28.
66. Lonn E, Held C, Arnold JM et al. Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial. Can J Cardiol 2006; 22 (1): 47–53.
67. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999; 354: 407–13.
68. McIlroy SP, Dynan KB, Lawson JT et al. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002; 33 (10): 2351–6.
69. Welch G, Loscalo J. Homocysteine and atherosclerosis. N Engl J Med 1998; 338: 15: 1042–50.
70. Sen S, Reddy PL, Grewal RP et al. Hyperhomocysteinemia is associated with aortic atheroma progression in stroke/TIA patients. Front Neurol 2010; 1: 131.
71. Leblhuber F, Walli J, Artner-Dworzak E et al. Hyperhomocysteinemia in dementia. J Neural Transm 2000; 107 (12): 1469–74.
72. Seshadri S, Beiser A, Selhub J et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 2002; 346 (7): 476–83.
73. Schafer JH, Glass TA, Bolla KI et al. Homocysteine and cognitive function in a population-based study of older adults. J Am Geriatr Soc 2005; 53 (3): 381–8.
74. Zorilova I.V., Suslina Z.A., Illarioshkin S.N., Kistenev B.A. Nasledstvenno obuslovlennaia gipergomotsisteinemiia v patogeneze ishemicheskogo insul'ta u lits molodogo vozrasta. Nevrol. zhurn. 2005; 10 (2): 14–7. [in Russian]
75. Loscalzo J. Homocysteine and dementias. N Engl J Med 2002; 346 (7): 466–8.
76. McMahon JA, Green TJ, Skeaff CM et al. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 2006; 354 (26): 2764–72.
77. Walker JG, Batterham PJ, Mackinnon AJ et al. Oral folic acid and vitamin B12 supplementation to prevent cognitive decline in community dwelling older adults with depressive symptoms – the Beyond Ageing Project: a randomized controlled trial. Am J Clin Nutr 2012; 95 (1): 194–203.
78. Kamchatnov P.R., Damulin I.V. Kognitivnye narusheniia pri defitsite vitamina V12, folievoi kisloty i gipergomotsisteinemii. Klinitsist 2015; 1: 18–23. [in Russian]
79. Clark C.M. Metabolic and nutritional disorders associated with dementia. In: J.C.Morris, J.E.Galvin, D.M.Holzman (eds.). Handbook of Dementing Illnesses. N.Y.: Marcel Dekker, Inc., 1994; p. 413–39.
80. Wahlund LO, Basun H, Waldemar G. Reversible or arrestable dementias. In: N.Qizilbash et al. (eds.). Evidence-based Dementia Practice. Oxford: Blackwell Sciences, 2002; р. 330–40.
81. Abyad A. Prevalence of vitamin B12 deficiency among demented patients and cognitive recovery with cobalamin replacement. J Nutr Health Aging 2002; 6 (4): 254–60.
82. Rietsema WJ. Unexpected recovery of moderate cognitive impairment on treatment with oral methylcobalamin. J Am Geriatr Soc 2014; 62 (8): 1611–2.
83. Clayton PT, Smith I, Harding В et al. Subacute combined degeneration of the cord, dementia, and parkinsonism due to an inborn error of folate metabolism. J Neurol Neurosurg Psychiatry 1986; 49: 920–7.
84. Heap BJ, Mumford JD. Chronic giardiasis with vitamin B12 and folate deficiency presenting with psychiatric symptoms. J Roy Amy Med Corps 1989; 135: 25–6.
85. Moore E, Mander A, Ames D et al. Cognitive impairment and vitamin B12: a review. Int Psychogeriatr 2012; 24 (4): 541–56.
86. Reynolds EH. Folic acid, ageing, depression, and dementia. BMJ 2002; 324 (7352): 1512–5.
87. Lancowsky P. Congenital malabsorption of folate. J Am Med 1970; 48: 580–3.
88. Luhby AL, Cooperman JM. Congenital megaloblastic anemia and progressive central nervous system degeneration. Further clinical and physiological characterization and therapy of syndrome due to inborn error of folate transport. American Pediatric Society, Inc., Annual Meeting, Atlantic City, 1967.
89. Lever EG, Elwes RD, Williams A et al. Subacutecombinated degeneration of the cord due to folate deficiency: response to methyl folate treatment. J Neurol Neurosurg Psychiatry 1986; 49: 1203–7.
90. Luhby AL, Eagle FJ, Roth Ε et al. Relapsing megaloblastic anemia in an infant due to a specific defect in gastrointestinal absorption of folic acid. J Am Dis Child 1961; 102: 482–3.
91. Damulin I.V. Dementsii pri defitsitarnykh sostoianiiakh i alkogolizme. Nevrol. zhurn. 2005; 5: 4–8. [in Russian]
92. Guidolin L, Vignoli A, Canger R. Worsening in seizure frequency and severity in relation to folic acid administration. Eur J Neurol 1998; 5 (3): 301–3.
93. Agnew-Blais JС, Wassertheil-Smoller S, Kang JH et al. Folate, vitamin B-6, and vitamin B-12 intake and mild cognitive impairment and probable dementia in the Women's Health Initiative Memory Study. J Acad Nutr Diet 2015; 115 (2): 231–41.
94. Razvodovskii Iu.E. Alkogol'noe porazhenie mozga. Med. novosti. 2006; 1: 13–7. [in Russian]
95. Gavrilova S.I. Farmakoterapiia bolezni Al'tsgeimera. 2-e izd., pererab. i dop. M., 2007; s. 360. [in Russian]
96. Damulin I.V. Bolezn' Al'tsgeimera i sosudistaia dementsiia. Pod red. N.N.Iakhno. M., 2002; s. 85. [in Russian]
97. Levin O.S. Diagnostika i lechenie dementsii v klinicheskoi praktike. M., 2010; s. 256. [in Russian]
98. Andrieux S, Amouyal K, Renish W et al. The consumption of vasodilators and Ginkgo biloba (Egb 761) in a population of 7598 women over the age of 75 years. Res Pract Alzheimer’s Dis 2001; 5: 57–68.
99. Preobrazhenskaia I.S. Nootropnye preparaty v geriatricheskoi praktike. RMZh 2004; 5 (12): 256–61. [in Russian]
100. Knopman DS. Current treatment of mild cognitive impairment and Alzheimer’s disease. Curr Neurol Nerosci Rep 2006; 6 (5): 365–71.
101. Grima NA, Pase MP, Macpherson H, Pipingas A. The effects of multivitamins on cognitive performance: A systematic review and meta-analysis. J Alzheimer’s Dis. 2012; 29: 561–9.
102. Kennedy DO, Haskell CF. Vitamins and cognition: What is the evidence? Drugs 2011; 71: 1957–71.
103. Heseker H, Kubler W, Pudel V, Westenhofer J. Interaction of vitamins with mental performance. Bibl Nutr Dieta 1995; 52: 43–55.
104. Kennedy DO, Veasey R, Watson A et al. Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males. Psychopharmacology 2010; 211: 55–68.
105. Kennedy DO, Veasey RC, Watson AW et al. Vitamins and psychological functioning: A mobile phone assessment of the effects of a B vitamin complex, vitamin C and minerals on cognitive performance and subjective mood and energy. Hum Psychopharmacol Clin Exp 2011; 26: 538–47.
106. Harris E, Kirk J, Rowsell R et al. The effect of multivitamin supplementation on mood and stress in healthy older men. Hum Psychopharmacol Clin Exp 2011; 26: 560–7.
107. Stough C, Scholey A, Lloyd J et al. The effect of 90 day administration of a high dose vitamin B – Complex on work stress. Hum Psychopharmacol Clin Exp 2011; 26: 470–6.
108. Haskell CF, Robertson B, Jones E et al. Effects of a multi-Vitamin/mineral supplement on cognitive function and fatigue during extended multi-Tasking. Hum Psychopharmacol Clin 2010; 25: 448–61.
109. www.berocca.ru.
110. McGarel C, Pentieva K, Strain JJ, McNulty H. Emerging roles for folate and related B-vitamins in brain health across the lifecycle. Proc Nutr Soc 2015; 74 (1): 46–55.
111. Scholey A, Bauer I, Neale C et al. Acute effects of different multivitamin mineral preparations with and without Guaraná on mood, cognitive performance and functional brain activation. Nutrients 2013; 5 (9): 3589–604.

________________________________________________